Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.23
-0.0133-0.04%
Post-market: 34.290.0633+0.18%19:30 EDT
Volume:4K
Turnover:120.34K
Market Cap:43.64M
PE:- -
High:34.42
Open:34.40
Low:34.10
Close:34.24
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.88
T/O Rate:0.28%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Amylyx Phase 3 data support FDA approval, says Citi

TIPRANKS
·
Aug 18

Eyconis Announces Initiation of First-in-Human Clinical Trial of Eyc-0305 in Treatment-NaÏVe Wet Age-Related Macular Degeneration Patients

THOMSON REUTERS
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors

Simply Wall St.
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

Rhythm Pharmaceuticals Appoints Manher “AJ” Joshi as Chief Medical Officer

Reuters
·
Aug 17

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer

THOMSON REUTERS
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

OmniAb Signs Global Ion Channel Collaboration Deal with Eli Lilly, Eyes up to $370 Million in Milestones

Reuters
·
Aug 17

Bristol Gate’s Richard Hamm Trims Eli Lilly Stake

TIPRANKS
·
Aug 15